Edit Module

Boehringer Ingelheim To Acquire Fort Dodge Products From Pfizer

Posted: Monday, Oct. 26, 2009, 2:16 p.m., EDT



Published:

Boehringer Ingelheim and its subsidiary Boehringer Ingelheim Vetmedica Inc. reported Oct. 26 that it will acquire a “significant portion” of the Fort Dodge Animal Health business from Pfizer Animal Health. Terms of the deal were not disclosed.

Pfizer Inc., parent company of Pfizer Animal Health, recently acquired Wyeth and its subsidiary Fort Dodge Animal Health. Pfizer and Wyeth began joint operations on Oct. 16.

The Boehringer Ingelheim-Pfizer deal includes products in the United States, Australia, Canada and South Africa, as well as two manufacturing and research facilities located in Fort Dodge, Iowa. Products being acquired in Europe are still subject to approval by European anti-trust authorities.

As part of the deal, Boehringer Ingelheim will acquire the Duramune line of vaccines for dogs, the Fel-O-Vax line of vaccines for cats and the Rabvac line of rabies vaccines manufactured and sold in the United States, Canada and Australia. The company will also acquire a portfolio of pet and equine pharmaceutical products currently sold in the United States.

In addition, the company will acquire cattle vaccines in the United States and Canada, including the Triangle, Pyramid and Presponse vaccine lines. Pharmaceutical products being acquired include Cydectin (moxidectin) for cattle and sheep as well as Polyflex (ampicillin sodium). The dairy portfolio includes the brands Today and Tomorrow.

Several Canadian swine vaccines are also included in the acquisition as are some cattle vaccines sold in Europe and South Africa.

Boehringer Ingelheim is headquartered in Ingelheim, Germany, and Boehringer Ingelheim Vetmedica Inc. is based in St. Joseph, Mo. Pfizer is in New York.


Related articles:

Pfizer Unveils Product Details of Fort Dodge Aquisition

Pfizer Closes Wyeth Acquisition Deal

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Zoetis launches Clavamox Chewable for dogs, cats

Zoetis announced the commercial launch of Clavamox Chewable (amoxicillin and clavulanate potassium tablets), which is effective in treating skin infections in dogs and cats, periodontal infections in dogs, and urinary tract infections in cats, according to the company.

​2017 National Veterinary Scholars Symposium exposes students to biomedical research

Approximately 650 veterinary students and researchers from 38 veterinary schools from the U.S., Canada, the Caribbean, the Netherlands, and France gathered Aug. 3-6 at the National Institutes of Health (NIH) to discuss innovative animal health research and the future of veterinary medicine.

Four reasons veterinary clients avoid regular checkups for their cats—and what you can do about it

A recent survey found 92 percent of cat owners say their cat’s health is important to them, but only half of all American cats taken to the veterinarian by their caretakers on a regular basis; inspire cat owners to participate in Take Your Cat to Vet Day on August 22.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module